The Association of Heterozygous p.R4810K of RNF213 and Long-Term Unfavorable Outcomes after Encephaloduroarteriosynangiosis in Chinese Pediatric Patients with Moyamoya Disease
Human Mutation · 2024
DOI: 10.1155/2024/1844190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Mutation, 2024. Verfasst von Qingbao Guo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Moyamoya Disease, Ubiquitin-Protein Ligases, Adenosine Triphosphatases. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Previous studies have established that heterozygous mutation for the p.R4810K variant can influence the severity of the clinical phenotype in patients with moyamoya disease (MMD) at disease onset. However, the relationship between the p.R4810K variant and the clinical phenotype of long-term unfavorable outcomes in Chinese pediatric patients remains unclear.
Objectives
The primary aim of this study was to examine the association of heterozygous p.R4810K of RNF213 and long-term unfavorable outcomes after encephaloduroarteriosynangiosis (EDAS) in Chinese pediatric patients with MMD.
Method
In this retrospective cohort study, we included 259 pediatric patients with MMD who possessed the known p.R4810K genotype. These individuals underwent EDAS along with genotyping analysis for p.R4810K via a TaqMan probe and the QuantStudio 6 Flex Real-Time PCR System. Subsequently, we evaluated their long-term outcomes. The variables we assessed were age at diagnosis, gender, p.R4810K genotypes, initial modified Rankin scale (mRS), clinical manifestations (such as hemorrhage and ischemia), posterior cerebral artery (PCA) involvement combined with angiographic stage, and their history of risk factors like hyperlipidemia and hyperhomocysteinemia. Furthermore, we scrutinized long-term unfavorable outcomes using both univariate analyses and multivariate logistic regression to identify independent predictive factors.
Results
This study enrolled 259 Chinese pediatric patients with MMD, which included both newly and previously diagnosed cases, who underwent EDAS. The cohort comprised 130 male participants (50.19%) and 129 female participants (49.81%), with a median onset age of 8 years (median, IQR: 6-12 years). Among these patients, homozygous mutations were exceptionally rare, identified in only 4 individuals (1.54%), while the prevalence of heterozygous mutations was relatively higher, observed in 85 children (32.82%). The multivariate logistic regression showed that several factors were significantly associated with long-term unfavorable outcomes: older age at diagnosis (OR, 0.82 [95% CI, 0.7-0.96], P = 0.014 ), onset with hematoma (OR, 12.76 [95% CI, 1.52-106.89], P = 0.019 ), initial mRS (OR, 24.53 [95% CI, 6.51-92.41], P < 0.001 ), perioperative infarction (OR, 22.16 [95% CI, 1.45-337.96], P = 0.026 ), and infarction during follow-up (OR, 14.5 [95% CI, 2.04-103.12], P = 0.008 ). Furthermore, the cumulative incidence of initial infarction suggested that pediatric patients with homozygous or heterozygous mutations typically present at a younger age and exhibit a higher incidence of initial infarction compared to those carrying wild-type genotypes.
Conclusions
The study suggests that the p.R4810K variant is associated with the onset age of MMD in Chinese pediatric patients, potentially impacting long-term outcomes. Surprisingly low recurrent stroke rates were observed across all genotypes, including homozygous individuals for the pathogenic variant, indicating that nongenetic factors may also play a role in the course and outcomes of MMD in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China.
- Medical School of Chinese PLA, Beijing, China.
- Department of Neurosurgery, Chinese PLA General Hospital, Beijing, China.
- Department of Neurosurgery, The Eighth Medical Centre, Chinese PLA General Hospital, Beijing, China.
ORCID-Profile: Cong Han, Xiangyang Bao, Lian Duan
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Guo, Q., Hao, F., Wang, Q. N., Li, J., Liu, S., Zou, Z., Liu, S., Wang, X., Yu, D., Gao, G., Zhang, Q., Pei, S., Feng, J., Yang, R., Wang, M., Fu, H., Han, C., Bao, X., & Duan, L. (2024). The Association of Heterozygous p.R4810K of RNF213 and Long-Term Unfavorable Outcomes after Encephaloduroarteriosynangiosis in Chinese Pediatric Patients with Moyamoya Disease. Human Mutation. https://doi.org/10.1155/2024/1844190
Vancouver
Guo Q, Hao F, Wang QN, Li J, Liu S, Zou Z, et al. The Association of Heterozygous p.R4810K of RNF213 and Long-Term Unfavorable Outcomes after Encephaloduroarteriosynangiosis in Chinese Pediatric Patients with Moyamoya Disease. Human Mutation. 2024. doi:10.1155/2024/1844190
BibTeX
@article{Guo2024,
author = {Guo, Qingbao and Hao, Fangbin and Wang, Qian-Nan and Li, Jingjie and Liu, Shitong and Zou, Zhengxing and Liu, Simeng and Wang, Xiaopeng and Yu, Dan and Gao, Gan and Zhang, Qian and Pei, Songtao and Feng, Jie and Yang, Rimiao and Wang, Minjie and Fu, Heguan and Han, Cong and Bao, Xiangyang and Duan, Lian},
title = {The Association of Heterozygous p.R4810K of RNF213 and Long-Term Unfavorable Outcomes after Encephaloduroarteriosynangiosis in Chinese Pediatric Patients with Moyamoya Disease},
journal = {Human Mutation},
year = {2024},
doi = {10.1155/2024/1844190}
}
EUVIMED